Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05296525
Title Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gamida Cell ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
Loyola University, Cardinal Bernardin Cancer Center Maywood Illinois 60153 United States Details
Dana-Farber/Mass General Brigham Cancer Care, Inc. Boston Massachusetts 02215 United States Details
Henry Ford Medical Center Detroit Michigan 48202 United States Details
Regents of the University of Minnesota Minneapolis Minnesota 55455 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field